Medical Device Maker Also Formalizes Clinical Advisory Board
PITTSBURGH, Jan. 7 /PRNewswire/ -- Cohera Medical, Inc., a rapidly growing
medical device company developing a suite of wound management systems and
surgical adhesives, announced today that it has expanded its executive
management team with the appointment of Chad Coberly as Vice President of
Clinical, Regulatory and Legal Affairs. Mr. Coberly has more than 15 years of
experience in the medical device industry, primarily in the areas of
regulatory/clinical affairs, compliance, quality systems, intellectual
property, business development, litigation and general legal affairs. He
brings experience from the law firm of Howard and Howard, the Surgical Group
of the Stryker Corporation, and most recently Zassi Medical Evolutions where
he served as the Vice President of Legal and Regulatory Affairs.
"Chad brings extensive domain-specific knowledge and industry experience
to our company," said Mr. Patrick Daly, President and CEO of Cohera Medical.
"In addition to his regulatory expertise, he has published articles in Food
and Drug Law Institute publications and has held board-level positions with
Medical Device Associations. We are fortunate to have him as a member of our
growing team."
Mr. Coberly holds a J.D. from Michigan State University and a bachelor's
degree in biomedical engineering from Tulane University. He also has completed
MBA studies at Boston University. He is admitted to practice before the U.S.
Patent and Trademark Office and is a member of the Michigan Bar.
Cohera has also formalized its Clinical Advisory Board, which includes the
following world renowned surgeons and scientists:
-- Peter Rubin, MD is the Founder and Director of the Life After Weight
Loss surgical body contouring program at the University of Pittsburgh,
and author of "Aesthetic Plastic Surgery After Massive Weight Loss." He
is the recipient of the Presidential Early Career Award for Scientists
and Engineers, the highest honor bestowed upon young scientists by the
United States government.
-- Russell F. Warren, MD is the Surgeon-in-Chief Emeritus of the Hospital
for Special Surgery (HSS) in Manhattan and Professor of Orthopedics at
the Weill Medical College of Cornell University. He is currently the
Team Physician for the New York Giants.
-- Richard M. Green, MD, FACS is currently chairman, Department of
Surgery, at Lenox Hill Hospital, in New York City. In 2005, he also
became co-director, Division of Peripheral and Vascular Intervention at
Lenox Hill Hospital.
-- Michael Buckley, MD is co-founder of Cohera Medical and co-inventor of
the company's core technology. He is an oral and maxillofacial surgeon
in private practice. Dr. Buckley serves as the national Treasurer of
the American Cleft Palate-Craniofacial Association.
"Cohera has attracted quite a prestigious group of advisors to provide
expert feedback on our efforts in new product development," said Mr. Daly. "We
look forward to working with them to create products that will continue to
revolutionize the practice of surgery in all disciplines."
About Cohera Medical, Inc.
Cohera Medical, Inc. is developing a revolutionary line of wound
management products and surgical adhesives. Our products are based on a unique
chemical design that is purely synthetic, easy to use, biocompatible and fully
resorbable. Our lead product in development, TissuGlu(TM) Wound Management
System, is a sprayable bonding agent for plastic surgery procedures.
TissuGlu(TM) adheres flaps of tissue after surgical procedures, eliminating
the spaces where fluid accumulates and reducing wound drainage. Pre-clinical
testing has shown that TissuGlu(TM) virtually eliminates seroma formation, one
of the most common complications of abdominoplasty procedures. Cohera is also
developing additional surgical adhesives targeting mesh fixation and small
bone fixation, which will fill similar market needs in both orthopedics and
general surgery. TissuGlu(TM) and the other Cohera products have not yet been
approved for medical use by the Food and Drug Administration (FDA) in the US
or by any other country's regulatory authority.
SOURCE Cohera Medical, Inc.
Dottie Clower, PhD, Vice President of Business Development and Operations of
Cohera Medical, Inc., +1-412-231-1500, dclower@coheramed.com; or Lynn M.
Brusco of the Pittsburgh Life Sciences Greenhouse, +1-412-770-1353
